These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

605 related items for PubMed ID: 26637774

  • 1. Uncommon histiocytic disorders: Rosai-Dorfman, juvenile xanthogranuloma, and Erdheim-Chester disease.
    Haroche J, Abla O.
    Hematology Am Soc Hematol Educ Program; 2015; 2015():571-8. PubMed ID: 26637774
    [Abstract] [Full Text] [Related]

  • 2. BRAF V600E mutation in Juvenile Xanthogranuloma family neoplasms of the central nervous system (CNS-JXG): a revised diagnostic algorithm to include pediatric Erdheim-Chester disease.
    Picarsic J, Pysher T, Zhou H, Fluchel M, Pettit T, Whitehead M, Surrey LF, Harding B, Goldstein G, Fellig Y, Weintraub M, Mobley BC, Sharples PM, Sulis ML, Diamond EL, Jaffe R, Shekdar K, Santi M.
    Acta Neuropathol Commun; 2019 Nov 04; 7(1):168. PubMed ID: 31685033
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. BRAF V600E mutation in pediatric intracranial and cranial juvenile xanthogranuloma.
    Techavichit P, Sosothikul D, Chaichana T, Teerapakpinyo C, Thorner PS, Shuangshoti S.
    Hum Pathol; 2017 Nov 04; 69():118-122. PubMed ID: 28504206
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of neuroimaging features of histiocytic neoplasms with central nervous system involvement: a retrospective study of 121 adult patients.
    Fan X, Liu T, Zhang Z, Sun J, Niu N, Mao C, Wang F, Li J, Zhou D, Cao X, Jin Z, Feng F.
    Eur Radiol; 2023 Nov 04; 33(11):8031-8042. PubMed ID: 37191919
    [Abstract] [Full Text] [Related]

  • 10. [An overview of histiocytosis].
    Tojo A.
    Rinsho Ketsueki; 2022 Nov 04; 63(5):363-367. PubMed ID: 35662158
    [Abstract] [Full Text] [Related]

  • 11. Successful treatment with cladribine of Erdheim-Chester disease with orbital and central nervous system involvement developing after treatment of Langerhans cell histiocytosis.
    Perić P, Antić B, Knezević-Usaj S, Radić-Tasić O, Radovinović-Tasić S, Vasić-Vilić J, Sekulović L, Tarabar O, Tukić L, Jovandić S, Magić Z.
    Vojnosanit Pregl; 2016 Jan 04; 73(1):83-7. PubMed ID: 26964390
    [Abstract] [Full Text] [Related]

  • 12. [Erdheim-Chester disease (ECD), an inflammatory myeloid neoplasia].
    Haroche J, Papo M, Cohen-Aubart F, Charlotte F, Maksud P, Grenier PA, Cluzel P, Mathian A, Emile JF, Amoura Z.
    Presse Med; 2017 Jan 04; 46(1):96-106. PubMed ID: 27234902
    [Abstract] [Full Text] [Related]

  • 13. High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses.
    Haroche J, Charlotte F, Arnaud L, von Deimling A, Hélias-Rodzewicz Z, Hervier B, Cohen-Aubart F, Launay D, Lesot A, Mokhtari K, Canioni D, Galmiche L, Rose C, Schmalzing M, Croockewit S, Kambouchner M, Copin MC, Fraitag S, Sahm F, Brousse N, Amoura Z, Donadieu J, Emile JF.
    Blood; 2012 Sep 27; 120(13):2700-3. PubMed ID: 22879539
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Advancements in the understanding and management of histiocytic neoplasms.
    Koh KN, Yoon SH, Kang SH, Kim H, Im HJ.
    Blood Res; 2024 Jul 04; 59(1):22. PubMed ID: 38963520
    [Abstract] [Full Text] [Related]

  • 19. Impact of BRAFV600E mutation on aggressiveness and outcomes in adult clonal histiocytosis.
    Razanamahery J, Godot A, Leguy-Seguin V, Samson M, Audia S, Bonnotte B.
    Front Immunol; 2023 Jul 04; 14():1260193. PubMed ID: 37809108
    [Abstract] [Full Text] [Related]

  • 20. Molecular and clinicopathologic characterization of pediatric histiocytoses.
    Hélias-Rodzewicz Z, Donadieu J, Terrones N, Barkaoui MA, Lambilliotte A, Moshous D, Thomas C, Azarnoush S, Pasquet M, Mansuy L, Aladjidi N, Jeziorski E, Marec-Berard P, Gilibert-Yvert M, Spiegel A, Saultier P, Pellier I, Pagnier A, Pertuisel S, Poiree M, Bodet D, Millot F, Isfan F, Stephan JL, Leruste A, Rigaud C, Filhon B, Carausu L, Reguerre Y, Kieffer I, Brichard B, Ben Jannet R, Bakari M, Idbaih A, Bodemer C, Cohen-Aubart F, Haroche J, Tazi A, Boudjemaa S, Fraitag S, Emile JF, Heritier S, French Histiocytosis Study Group.
    Am J Hematol; 2023 Jul 04; 98(7):1058-1069. PubMed ID: 37115038
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.